Table: begin end state 1 19 cytoplasmic 20 41 transmembrane 42 46 non-cytoplasmic 47 66 transmembrane 67 85 cytoplasmic 86 106 transmembrane 107 125 non-cytoplasmic 126 145 transmembrane 146 153 cytoplasmic 154 176 transmembrane 177 195 non-cytoplasmic 196 220 transmembrane 221 240 cytoplasmic 241 261 transmembrane 262 291 non-cytoplasmic 292 311 transmembrane 312 342 cytoplasmic 343 364 transmembrane 365 369 non-cytoplasmic 370 389 transmembrane 390 408 cytoplasmic 409 431 transmembrane 432 436 non-cytoplasmic 437 455 transmembrane 456 473 cytoplasmic
Input: >AO353_18555 MSGQNSHSGTLQRGLKNRHIQLIALGGAIGTGLFLGSAGVLKSAGPSMILGYAICGFIAF MIMRQLGEMIVEEPVAGSFSHFAHKYWGGFAGFLSGWNCWILYILVGMSELTAVGKYVHY WWPDVPTWASAAVFFVMINAINLANVKVFGEAEFWFAIIKVVAIVGMIALGSYLLVSGHG GPQASVSNLWEHGGFFPNGVSGLVMAMAIIMFSFGGLEMLGFTAAEADKPKTVIPKAINQ VIYRILIFYIGALVVLLSLTPWDSLLVSLNASGDAYSGSPFVQVFSMLGSKTAAHILNFV VLTAALSVYNSGTYCNSRMLLGMAEQGDAPKGLAKIDKRGVPVRSILASAAVTFVAVVMN YLIPQHALELLMSLVVATLVINWAMISYSHFKFRQHMNRTKQTPLFKALWYPYGNYICLA FVAFILCIMLMIPGIQISVYAIPVWVLFMWVCYNIKNKRSAQHALNAAASAVK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server